Press releases
- Dexcom Announces Upcoming Conference Presentation
- Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
More ▼
Key statistics
As of last trade Dexcom Inc (DC4:STU) traded at 107.60, -18.15% below its 52-week high of 131.46, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 108.82 |
---|---|
High | 108.82 |
Low | 107.60 |
Bid | 108.20 |
Offer | 109.60 |
Previous close | 115.48 |
Average volume | 287.14 |
---|---|
Shares outstanding | 397.68m |
Free float | 396.22m |
P/E (TTM) | 78.28 |
Market cap | 47.23bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼